Kristen Hansen-Peterman, MD
Obstetrics & Gynecology · Austin, TXNPI 1134135486
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $108 of the $122 with a category attached, or 89.0%. 4 manufacturers reported payments, led by Therapeuticsmd, Inc. at 47.0% of the total. Reporting peaked in 2022 at $70 and has fallen 80.9% since, to $13 in 2024. That places this record below the midpoint for obstetrics & gynecology clinicians in TX, where the typical reported total is $863.
Across 7 payments — averaging $17.39 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Therapeuticsmd, Inc.$57
- AbbVie$26
- Hologic Sales And Service, LLC$25
- Millicent US Inc$13
Across 36 payments — averaging $2621.42 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Evofem Biosciences, Inc.$53K
- Exeltis, USA Inc.$41K
What the payments were for
- Food & beverage$10889%
- Education$1311%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Therapeuticsmd, Inc. | 3 | $57 |
| AbbVie | 2 | $26 |
| Hologic Sales And Service, LLC | 1 | $25 |
| Millicent US Inc | 1 | $13 |
How this compares
$122 in reported general payments places this provider in the 15th percentile of 3,099 obstetrics & gynecology providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Estradiol | 138 | $9,775 |
| PremarinEstrogens, Conjugated | 24 | $9,489 |
| PremproEstrogen,con/M-Progest Acet | 16 | $7,669 |
| EstringEstradiol | 14 | $7,380 |
| ProgesteroneProgesterone, Micronized | 21 | $1,197 |
| ValacyclovirValacyclovir Hcl | 21 | $794 |
| Medroxyprogesterone Acetate | 12 | $268 |
Paid to pharmacies, not to this prescriber.
Other obstetrics & gynecology in Austin
- Devin GarzaAustin$2M
- Shawn TassoneAustin$1.3M
- Renu ChalasaniAustin$156K
- Sharyl Brasher-GilesAustin$42K
- Dale StovallDallas$590K
- Karyn-Anne CumberbatchMissouri City$452K
- Robert AsgharianEl Paso$366K
- Catherine HansenWebster$357K
- Lisa JukesBee Cave$270K
- Susan CrockettLive Oak$269K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.